Literature DB >> 51

Conformational changes induced in a homogeneous anti-type III pneumococcal antibody by oligosaccharides of increasing size.

J C Jaton, H Huser, D G Braun, D Givol, I Pecht, J Schlessinger.   

Abstract

The circular polarization of luminescence (CPL) emitted by tryptophan residues was used as a sensitive probe for measuring ligand-induced structural changes in a homogeneous type III pneumococcal antibody. A series of oligosaccharide ligands of increasing size derived from type III polysaccharide by partial acid hydrolysis was assayed. Ligand-induced changes in the circular polarization of fluorescence of the antibody were observed for all antigens tested, including tetra-, hexa-, and octasaccharides and a 16-residue oligomer, the largest changes being recorded upon interaction with the intact soluble type III pneumococcal (SIII) polysaccharide. When Fab' or F(ab')2 fragments were used instead of the antibody IgG for binding of SIII polysaccharide, the extent of conformational changes was decreased. This suggests interactions between Fab and Fc portions in the IgG molecule and subsequent conformational changes in Fc part upon antigen binding. Reduction of interchain disulfide bonds abolished the additional spectral changes attributed to the Fc part but not the changes observed in the Fab part, thus suggesting that the presence of the interchain disulfide bond in the hinge region is required for maximal CPL changes to occur. Small monovalent ligands, i.e., the tetra-, hexa-, and octasaccharides, were capable of inducing CPL changes in the Fab part of the antibody molecule as well as CPL changes attributed to the Fc portion. A multivalent ligand containing about 16 sugar residues appears to be the minimal antigenic size required for triggering conformational changes attributed to the Fc part, similar to those seen in the interaction with the whole polysaccharide antigen.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 51     DOI: 10.1021/bi00695a014

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  9 in total

1.  Quantitative analysis of the interaction between immune complex and C1q complement subcomponent. The role of interdomain interactions in rabbit IgG in binding of C1q to immune precipitates.

Authors:  F Vonderviszt; J Török; S Lakatos; F Kilár; P Závodszky
Journal:  Biochem J       Date:  1987-04-15       Impact factor: 3.857

2.  A general interactive model for B cell activation. I. The theory.

Authors:  A J Rosenspire; R Rosen; D M Jacobs
Journal:  Cell Biophys       Date:  1981-03

Review 3.  Immuno-receptors: from recognition to signaling and function.

Authors:  Israel Pecht
Journal:  Eur Biophys J       Date:  2018-03-29       Impact factor: 1.733

Review 4.  Spatial structure of immunoglobulin molecules.

Authors:  R Huber
Journal:  Klin Wochenschr       Date:  1980-11-17

5.  Dimeric, trimeric and tetrameric complexes of immunoglobulin G fix complement.

Authors:  J K Wright; J Tschopp; J C Jaton; J Engel
Journal:  Biochem J       Date:  1980-06-01       Impact factor: 3.857

6.  Evidence for a long-range conformational change induced by antigen binding to IgM antibody.

Authors:  J C Brown; M E Koshland
Journal:  Proc Natl Acad Sci U S A       Date:  1977-12       Impact factor: 11.205

7.  Induction of an Fc conformational change by binding of antigen: the generation of protein A-reactive sites in chicken immunoglobulin.

Authors:  T Barkas; C M Watson
Journal:  Immunology       Date:  1979-03       Impact factor: 7.397

Review 8.  Intramolecular immunological signal hypothesis revived--structural background of signalling revealed by using Congo Red as a specific tool.

Authors:  A Jagusiak; L Konieczny; M Krol; P Marszalek; B Piekarska; P Piwowar; I Roterman; J Rybarska; B Stopa; G Zemanek
Journal:  Mini Rev Med Chem       Date:  2015       Impact factor: 3.862

Review 9.  IgG cooperativity - Is there allostery? Implications for antibody functions and therapeutic antibody development.

Authors:  Danlin Yang; Rachel Kroe-Barrett; Sanjaya Singh; Christopher J Roberts; Thomas M Laue
Journal:  MAbs       Date:  2017-08-16       Impact factor: 5.857

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.